131 related articles for article (PubMed ID: 18322355)
1. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
[TBL] [Abstract][Full Text] [Related]
2. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
3. Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan.
Imamura T; Sato T; Shiota Y; Kanegane H; Kudo K; Nakagawa S; Nakadate H; Tauchi H; Kamizono J; Morimoto A
Int J Hematol; 2010 May; 91(4):646-51. PubMed ID: 20361277
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
[TBL] [Abstract][Full Text] [Related]
5. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
Stine KC; Saylors RL; Williams LL; Becton DL
Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
[TBL] [Abstract][Full Text] [Related]
6. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
[TBL] [Abstract][Full Text] [Related]
7. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL
J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800
[TBL] [Abstract][Full Text] [Related]
8. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
[TBL] [Abstract][Full Text] [Related]
9. Cladribine activity in adult langerhans-cell histiocytosis.
Saven A; Burian C
Blood; 1999 Jun; 93(12):4125-30. PubMed ID: 10361109
[TBL] [Abstract][Full Text] [Related]
10. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
11. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
[TBL] [Abstract][Full Text] [Related]
12. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine.
Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M
Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W
Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.
Stine KC; Saylors RL; Saccente S; McClain KL; Becton DL
Pediatr Blood Cancer; 2004 Jul; 43(1):81-4. PubMed ID: 15170896
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.
Weitzman S; Wayne AS; Arceci R; Lipton JM; Whitlock JA
Med Pediatr Oncol; 1999 Nov; 33(5):476-81. PubMed ID: 10531572
[TBL] [Abstract][Full Text] [Related]
17. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J
Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085
[TBL] [Abstract][Full Text] [Related]
18. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis.
Suzuki D; Kobayashi R; Sano H; Kishimoto K; Yasuda K; Nakanishi M; Nagashima T; Kobayashi K
Int J Hematol; 2013 Jun; 97(6):782-5. PubMed ID: 23616222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
